“…Wenxin granule can increase ejection fraction and cardiac index, decrease the levels of BNP and Ang-II, therefore improving the left ventricular systolic function in HF patients. In addition, Wenxin granule can inhibit TGF-β/Smads signaling pathway, delay the development of myocardial fibrosis, and improve the prognosis of patients with paroxysmal atrial fibrillation [ 227 ]. Wenxin granule can act on potassium, sodium and calcium plasma channels to alleviate myocardial ischemia and hypoxia through producing postrepolarization refractoriness, prolonging the effective refractory period and shortening action potential duration.…”